NCT06435897: Autoimmune Disease Treatment With Mesenchymal Stem Cells (MSCs) and CAR-T Cells
- State
- Not started
- Phase
- Phase 1 and Phase 2
- People
- 30 planned
- Started
- 30 Jun 2027
- Primary completion
- 31 Dec 2028
- Arms
- MSC combined with 4SCAR T-cell therapy for autoimmune diseases
- Results
- None posted
- 30 May 2024: Trial registered